Even Healthcare Raises $50M to Reshape India's Hospital Economics

A $50 Million Bet on Value-Based Healthcare

Even Healthcare, an Indian startup founded in 2021, has secured $50 million in Series B funding led by Khosla Ventures, with participation from Alpha Wave. The round values the company at $300 million—triple its valuation from 18 months prior—bringing total capital raised to over $120 million. Even is attacking a fundamental problem in India's healthcare system: hospitals and doctors have financial incentives to recommend unnecessary tests, procedures, and extended stays, inflating costs for patients and insurers alike.

Dismantling the Volume-Based Model

Indian hospitals traditionally generate revenue by maximizing the number of treatments, procedures, and hospital days per patient, regardless of clinical necessity. Even is inverting this logic by building and operating its own hospitals where doctors earn fixed salaries rather than compensation tied to procedure volume. Hospital managers, marketing staff, and executives face the same principle—incentives reward better patient outcomes and reduced costs, not higher treatment volume. Every employee, including physicians, receives equity stakes in the company, aligning individual financial interests with long-term organizational performance rather than short-term revenue maximization.

The startup opened two hospitals in Bengaluru that reached operational profitability (excluding depreciation) within a year. Plans call for five additional hospitals in the same city over the next six months, funded by the new Series B capital. Leases on hospital buildings run for 20 years, giving Even operational stability as it invests in infrastructure and medical equipment.

Measurable Results Driving Investor Confidence

Even publishes clinical outcome data transparently, using established medical scoring systems to track patient recovery. For knee replacements, the company tracks pain and mobility using the Oxford Knee Score and compares results against other healthcare systems. The early numbers are compelling: unplanned readmission rates stand below 1% versus an 8-15% industry benchmark. Patients spend roughly 40% less time hospitalized, and Even claims its approach has saved insurers over ₹500 million (approximately $5.27 million). The startup tracks approximately 250,000 members and has completed more than 750,000 patient interactions since launch, encompassing consultations, diagnostics, and surgeries.

Vinod Khosla, founder of Khosla Ventures, emphasized that Even's model combines financing, technology, and care delivery to reward better health outcomes rather than service utilization. The firm has backed Even since its seed round in 2021 and viewed the hospital performance metrics as sufficient cause to lead this funding round. Jai Sajnani, a Khosla partner, cited strong early performance as the key decision factor for the investment.

Revenue Model and Insurance Partnerships

Even generates revenue primarily from patients directly paying for treatment. The startup also monetizes relationships with insurers and is developing a model where insurers compensate Even for hospitalizations it helps prevent—a shift from traditional per-treatment payment structures. This nascent revenue stream could prove critical if hospitals increasingly adopt value-based contracting, particularly in emerging markets where cost containment remains a dominant concern.

Financial Reality: Losses Amid Growth

Despite strong clinical metrics and investor enthusiasm, Even remains unprofitable. The startup posted a net loss of ₹902 million (approximately $9.50 million) in fiscal 2025, up nearly 25% year-over-year, against revenue of just ₹272 million (about $2.86 million). In August, Even laid off approximately 350 employees as part of a restructuring, though affected workers received severance, extended health insurance, and accelerated equity vesting. The company now employs roughly 650 people, including around 300 full-time doctors.

Founder Mayank Banerjee acknowledged that Even could reach profitability within months if expansion spending ceased, but the startup is deliberately prioritizing growth over near-term profitability. The strategy reflects confidence in the market opportunity and the thesis that building multiple hospitals quickly will establish Even as a category leader in value-based care across India.